Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
US8993317B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2010 |
| Grant date | Mar 31, 2015 |
| Priority date | — |
| Expiry date | Sep 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/50
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with reduced or no contaminating baculoviral virions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.